A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight (SURMOUNT-1)
Obesity & Weight Control
What is the purpose of this trial?
This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weight. The study has two phases: A main phase and an extension phase. The main phase of the study will last 72 weeks (14 visits). Participants with prediabetes will continue in the extension for another 2 years.
- Ages18 years and older
- Trial withEli Lilly and Company
- Start Date07/22/2020
- End Date02/27/2022
- Last Updated07/28/2020
- Study HIC#2000026861